Bifogade filer
PDF
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Large Cap Stockholm |
| Sektor | Hälsovård |
| Industri | Vård & Omsorg |
Medicover has released its Social Finance Investor Report for 2023. The social finance framework was established in connection with Medicover's second Schuldschein issue in 2021. The social financing framework is a use-of-proceeds structure and aims to contribute to the World Bank's Universal Health Coverage goals, ensuring that people have access to essential healthcare services.
The 2023 report summarises investments in eligible projects covering the 12 months to September 2023, with a total of €60m in the 9 months to September 2023, and €602m invested in eligible projects since 2016. The report can be found on Medicover.com (https://www.medicover.com/sites/default/files/Social_Finance_Investor_Report_2023.pdf).
Lack of health infrastructure is one of the global development challenges, which Medicover has continuously aimed to alleviate aligned with the World Bank's Universal Health Coverage goals (UHC). Improving and increasing access for communities to healthcare requires significant investments in infrastructure and projects that can then bring about positive social impact and improvement on quality of life. Medicover makes use of debt instruments to finance these investments with allocation of the proceeds from the debt instruments under the Social Bond Framework and adherence to the Framework principles. Medicover not only achieves its UHC goals through infrastructure but also in bringing together, educating, and developing the staff that operate the facilities which are as, if not more, important than the infrastructure itself. In addition, Medicover creates healthcare financing models to support communities to afford health provision.
Some of the highlights of projects in the report, include the hospital in Bucharest, Romania opened in June 2023, The Pune, India Hospital opened in January 2023 and the new central lab in Frankfurt Oder, Germany, among many others.
For further information, please contact:
Hanna Bjellquist, Head of Investor Relations
+46 703 033 272
hanna.bjellquist@medicover.com
Medicover is a leading international healthcare and diagnostic services company and was founded in 1995. Medicover operates a large number of ambulatory clinics, hospitals, specialty-care facilities, laboratories and blood-drawing points and the largest markets are Poland, Germany, Romania and India. In 2022, Medicover had revenue of €1,510 million and more than 44,000 employees. For more information, go to www.medicover.com